Centerpoint Advisors’s Tenet Healthcare THC Stock Holding History

Centerpoint Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-375	Closed	-$20K	–	417
2022 Q2	$20K	Buy	+375	New	+$26.1K	0.01%	189

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $882M AUM 62.77% 1-Year Est. Return

Centerpoint Advisors's THC Position: Q3 2022 in Review

Centerpoint Advisors sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 375 shares — an estimated $20K sold.

Centerpoint Advisors first reported a position in THC in Q2 2022 and held it in 1 quarter. The position peaked at $20K in Q2 2022. 360 funds tracked by Wall St. Rank hold THC as of Q3 2022.

Centerpoint Advisors reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
Centerpoint Advisors sold 375 Tenet Healthcare shares in Q3 2022, an estimated $20K.
Centerpoint Advisors first reported a position in Tenet Healthcare in Q2 2022 and held it in 1 quarter.
Centerpoint Advisors's Tenet Healthcare position peaked at $20K in Q2 2022.
360 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Centerpoint Advisors's 13F filing for Q3 2022, filed 13 Oct 2022.